Similar Search Results

Principles of pharmacoeconomics

Bootman, J. Lyle (ed.); Townsend, Raymond J. (contributor); … - 1996 - 2. ed.

Persistent link: https://www.econbiz.de/10000563687

Hatch Waxman Act and the Indian pharmaceutical firms : an analysis

Sahay, Arvind; Saini, Gordhan Kumar - In: Foreign trade review : quarterly journal of Indian … 43 (2008) 2, pp. 3-35

Persistent link: https://www.econbiz.de/10003784821

Pharmaceutical price regulation : public perceptions, economic realities, and empirical evidence

Vernon, John A.; Golec, Joseph - 2008

Persistent link: https://www.econbiz.de/10003779330

Prescription drug price increases : hearing before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce, House of Representatives, 99th Congress,...

1986

Persistent link: https://www.econbiz.de/10000786666

An empirical investigation of consumers' procurement of pharmaceutical products via online retail channels

Rajamma, Rajasree K.; Pelton, Lou E. - In: Psychology & marketing 26 (2009) 10, pp. 865-887

Persistent link: https://www.econbiz.de/10003896792

Monopoly pricing under a Medicaid-style most-favored-customer clause and its welfare implication

Klibanoff, Peter; Kundu, Tapas - 2009

To control Medicaid's increasing expenditure on reimbursement of outpatient prescription drugs, the Omnibus Budget Reconciliation Act of 1990 included a rebate program that featured a most favored customer (MFC) clause. This clause guarantees that Medicaid gets a fixed rebate on each unit of...

Persistent link: https://www.econbiz.de/10003898336